Skip to main content
. 2023 Aug 21;9(9):e19366. doi: 10.1016/j.heliyon.2023.e19366

Table 1.

Basic clinical information of patients.

Index Young group Aged group Aged + MT group Adjusted P1-value Adjusted P2-value Adjusted P3-value
Retrieved oocytes (n) 51 55 54
Age(years) 27.23 ± 2.74 37.68 ± 2.56 36.60 ± 3.50 <0.0001 <0.0001 0.8406
Infertility duration(years) 2.23 ± 1.01 5.24 ± 3.78 3.50 ± 2.12 0.0134 >0.9999 0.3801
BMI (kg/m2) 22.42 ± 3.24 22.07 ± 2.15 23.33 ± 2.86 >0.9999 >0.9999 0.5078
FSH (IU/L) 7.48 ± 1.87 7.77 ± 2.40 7.97 ± 2.09 >0.9999 >0.9999 >0.9999
LH (IU/L) 11.62 ± 6.85 4.87 ± 2.59 4.67 ± 3.63 <0.0001 0.0004 >0.9999
E2 (pmol/L) 59.84 ± 93.28 372.7 ± 1262 233.3 ± 300.4 >0.9999 >0.9999 >0.9999
P (nmol/L) 84.98 ± 84.83 4.17 ± 8.74 2.07 ± 0.82 <0.0001 <0.0001 >0.9999
PRL (ng/ml) 8.46 ± 9.34 12.52 ± 5.65 23.35 ± 46.35 >0.9999 0.2214 0.3709
T (nmol/L) 1.42 ± 1.19 3.46 ± 10.40 1.16 ± 0.45 >0.9999 >0.9999 >0.9999

P1: Young group & Aged group P2: Young group & Aged + MT group P3: Aged group & Aged + MT group. BMI: Body mass index; FSH: Follicle-stimulating hormone; LH: Luteinizing hormone; E2: Estradiol; P: Progesterone; PRL: Prolactin; T: Testosterone; HCG: Human chorionic gonadotropin. Measurement data are presented as means ± standard deviations (SD); comparisons between two groups were performed using the t-test.